Company Filing History:
Years Active: 2006
Title: David Sterling: Innovator in Cognitive and Menopausal Disorder Treatments
Introduction
David Sterling is a notable inventor based in Branchburg, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of cognitive and menopausal disorders. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
David Sterling holds a patent for "Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate." This invention focuses on methods for treating fatigue, neurobehavioral slowing, and other cognitive disorders associated with cancers and their treatments. Additionally, it addresses disorders related to menopause, including executive function defects. The methods involve administering a composition that is substantially free of L-threo methylphenidate and erythro forms of methylphenidate.
Career Highlights
David Sterling is associated with Celgene Corporation, where he has been able to apply his expertise in developing innovative treatments. His work has been instrumental in advancing medical solutions for patients suffering from cognitive and menopausal disorders.
Collaborations
Some of his notable coworkers include Jerome B Zeldis and Herbert Faleck. Their collaboration has contributed to the success of various projects within the company.
Conclusion
David Sterling's contributions to the field of medicine through his patent and work at Celgene Corporation highlight his commitment to improving patient care. His innovative methods for treating cognitive and menopausal disorders represent a significant advancement in medical science.